Metastatic relapse in children with solid tumors is mainly caused by system
ic pretreatment dissemination of occult tumor cells. Therefore the initial
detection of undetected metastases could have a clinical impact on the prog
nosis (i.e. new initial staging) and therapy for children with cancer At la
ter stage it is useful to determine the presence and change in the number o
f residual malignant cells in order to adjust and/or select adjuvant therap
ies and techniques (i.e. autologous bone marrow transplantation, leukaphere
sis...), Over the past decade, sensitive immunocytochemical and molecular a
ssays have been developped which permit the identification of disseminated
cancer cell Actually tumor cell contamination can be detected in bone marro
w or in peripheral blood of children with following cancers: neuroblastoma,
Ewing tumor, alveolar rhabdomyosarcoma, PNETs. In this review, focus is on
the recent technical achievements in the detection of occult cancer cells
in bone marrow and in blood and a discussion of their usefulness for clinic
al trials.